WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-10 08:54 am Sale |
2023-04-28 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-13,340,377 (Position Closed) |
Filing |
| 2023-02-06 2:53 pm Sale |
2022-12-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
WELLINGTON MANAGEMENT CO LLP | 13,340,377 8.700% |
-3,999,210 (-23.06%) |
Filing |
| 2022-02-04 09:21 am Sale |
2021-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
WELLINGTON MANAGEMENT CO LLP | 17,339,587 10.590% |
-4,313,962 (-19.92%) |
Filing |
| 2021-02-04 09:45 am Sale |
2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
WELLINGTON MANAGEMENT CO LLP | 21,653,549 13.530% |
-124,152 (-0.57%) |
Filing |